COVID-19 Living Evidence. (2020, October 23). Weekly update of COAP As of 23.10.2020, we have indexed 80588 publications: 8902 pre-prints 71686 peer-reviewed publications Pre-prints: BioRxiv, MedRxiv Peer-reviewed: PubMed, EMBASE https://t.co/RaDy1Wm4Hq https://t.co/FYRaYPe8oG [Tweet]. @evidencelive. https://twitter.com/evidencelive/status/1319578431848353793

Wang, C., Li, W., Drabek, D. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11, 2251 (2020). https://doi.org/10.1038/s41467-020-16256-y

Proteus Vulgaris Characteristics – Biofield Treatment Analysis Biofield energy treatment is an alternative therapy approach that is studied in this research to bring the positive alternations in the characteristics of Proteus Vulgaris.

Proteus Vulgaris - Hospital Acquired Infections Proteus Vulgaris is a gram-negative bacterium that is ranked third as the cause of hospital-acquired infections. The present study was undertaken to study the impact of an alternative energy treatment on properties of Proteus Vulgaris.

Study of Proteus Vulgaris Antimicrobials Susceptibility Proteus Vulgaris antimicrobials susceptibility analysis shows changes in minimum inhibitory concentration and susceptibility patterns as compared to control sample after biofield energy treatment.

Proteus Vulgaris - Impact of Human Energy Treatment Biochemical test results shows the impact of human energy treatment on phenotyping and genotyping characteristics of Proteus Vulgaris. Read here to know about this study.